Profile data is unavailable for this security.
About the company
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
- Revenue in USD (TTM)0.00
- Net income in USD-78.59m
- Incorporated2022
- Employees36.00
- LocationOculis Holding AGBahnhofstrasse 7ZUG 6300SwitzerlandCHE
- Phone+41 217113970
- Websitehttps://oculis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc | 0.00 | -95.90m | 572.23m | 66.00 | -- | 2.18 | -- | -- | -1.31 | -1.31 | 0.00 | 3.11 | 0.00 | -- | -- | 0.00 | -36.84 | -41.34 | -38.72 | -45.70 | -- | -- | -- | -31,010.30 | -- | -- | 0.00 | -- | -- | -- | -49.49 | -- | -26.60 | -- |
| Third Harmonic Bio Inc | 0.00 | -39.20m | 585.23m | 51.00 | -- | 2.16 | -- | -- | -0.9694 | -0.9694 | 0.00 | 6.59 | 0.00 | -- | -- | 0.00 | -13.36 | -- | -13.66 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 12.32 | -- | -- | -- |
| Organogenesis Holdings Inc | 448.39m | -16.54m | 587.31m | 862.00 | -- | 2.23 | -- | 1.31 | -0.125 | -0.125 | 3.38 | 1.99 | 1.00 | 4.27 | 4.49 | 520,176.30 | -3.70 | 5.46 | -4.51 | 6.90 | 75.14 | 74.94 | -3.69 | 4.81 | 2.42 | 8.33 | 0.2001 | 0.00 | -3.94 | 17.49 | -68.16 | -- | 67.34 | -- |
| Y-mAbs Therapeutics Inc | 84.55m | -23.86m | 587.43m | 100.00 | -- | 6.38 | -- | 6.95 | -0.541 | -0.541 | 1.92 | 2.06 | 0.677 | 1.13 | 4.36 | 845,530.00 | -19.11 | -44.23 | -23.55 | -50.45 | 88.89 | -- | -28.22 | -181.13 | 3.54 | -- | 0.00 | -- | 29.96 | -- | 77.58 | -- | -- | -- |
| Alumis Inc | 0.00 | -189.03m | 588.10m | 128.00 | -- | -- | -- | -- | -3.65 | -3.65 | 0.00 | 3.87 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -142.57 | 0.00 | -- | -- | -- | -38.47 | -- | -- | -- |
| Sana Biotechnology Inc | 0.00 | -305.81m | 591.76m | 328.00 | -- | 2.03 | -- | -- | -1.41 | -1.41 | 0.00 | 1.31 | 0.00 | -- | -- | 0.00 | -51.36 | -38.99 | -56.78 | -42.70 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -5.11 | -- | 112.71 | -- |
| ACELYRIN Inc | 0.00 | -299.80m | 596.85m | 130.00 | -- | 1.05 | -- | -- | -3.06 | -3.06 | 0.00 | 5.71 | 0.00 | -- | -- | 0.00 | -40.33 | -- | -43.71 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -489.21 | -- | -- | -- |
| Astria Therapeutics Inc | 0.00 | -93.24m | 598.67m | 59.00 | -- | 2.31 | -- | -- | -2.30 | -2.30 | 0.00 | 6.32 | 0.00 | -- | -- | 0.00 | -32.43 | -64.48 | -33.78 | -68.34 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -40.62 | -- | -- | -- |
| ProKidney Corp | 0.00 | -38.68m | 599.63m | 163.00 | -- | -- | -- | -- | -0.5905 | -0.5905 | 0.00 | -7.73 | 0.00 | -- | -- | 0.00 | -27.97 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0003 | -- | -- | -- | 67.17 | -- | -- | -- |
| Oculis Holding AG | 0.00 | -78.59m | 614.49m | 36.00 | -- | 5.74 | -- | -- | -2.01 | -2.01 | 0.00 | 2.56 | 0.00 | -- | -- | 0.00 | -54.70 | -- | -68.03 | -- | -- | -- | -- | -- | -- | -138.75 | 0.0129 | -- | -- | -- | -129.47 | -- | -- | -- |
| Mind Medicine (MindMed) Inc | 0.00 | -97.80m | 615.62m | 57.00 | -- | 2.61 | -- | -- | -1.99 | -1.99 | 0.00 | 3.21 | 0.00 | -- | -- | 0.00 | -42.40 | -- | -49.28 | -- | -- | -- | -- | -- | -- | -- | 0.0849 | -- | -- | -- | -68.55 | -- | -- | -- |
| Mineralys Therapeutics Inc | 0.00 | -153.25m | 619.10m | 28.00 | -- | 2.61 | -- | -- | -3.27 | -3.27 | 0.00 | 4.76 | 0.00 | -- | -- | 0.00 | -56.16 | -- | -61.19 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -141.28 | -- | -- | -- |
| AnaptysBio Inc | 57.17m | -165.66m | 631.40m | 117.00 | -- | 7.48 | -- | 11.04 | -6.07 | -6.07 | 2.09 | 2.77 | 0.1166 | -- | 7.39 | 488,649.60 | -33.78 | -18.08 | -36.91 | -18.96 | -- | -- | -289.75 | -269.21 | -- | -- | 0.00 | -- | 66.78 | 27.97 | -27.11 | -- | -5.36 | -- |
Data as of Nov 14 2024. Currency figures normalised to Oculis Holding AG's reporting currency: US Dollar USD
2.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| abrdn, Inc.as of 30 Sep 2024 | 820.55k | 1.97% |
| Banque Lombard Odier & Cie SA (Investment Management)as of 30 Sep 2024 | 95.75k | 0.23% |
| Landsbr�f hfas of 04 Oct 2024 | 95.10k | 0.23% |
| ExodusPoint Capital Management LPas of 30 Jun 2024 | 50.37k | 0.12% |
| Merrill Lynch, Pierce, Fenner & Smith, Inc. (Invt Mgmt)as of 30 Jun 2024 | 17.16k | 0.04% |
| UBS Financial Services, Inc.as of 30 Jun 2024 | 16.41k | 0.04% |
| Geode Capital Management LLCas of 30 Jun 2024 | 14.94k | 0.04% |
| UBS Securities LLCas of 30 Jun 2024 | 94.00 | 0.00% |
| DuPont Capital Management Corp.as of 30 Sep 2024 | 4.00 | 0.00% |
| RBC Dominion Securities, Inc.as of 30 Jun 2024 | 4.00 | 0.00% |
More ▼
Data from 30 Jun 2024 - 04 Oct 2024Source: FactSet Research Systems Inc.
